Glucose Fresenius (Glucose Monohydrate)

Glucose Fresenius is used in clinical practice primarily as an intravenous carbohydrate source and solvent for drug dilution.

• To provide rapid energy to patients with hypoglycemia or during peri‑operative fasting.
• As a carrier solution for the reconstitution of lyophilized medications administered intravenously.
• For maintenance of fluid and electrolyte balance in patients requiring parenteral nutrition.
• To correct or prevent low blood glucose levels during critical care or trauma resuscitation.
• As an osmotic agent in certain diagnostic or therapeutic infusion protocols.

Adverse reactions to Glucose Fresenius are generally infrequent, but they can be categorized by frequency and severity.

Common

• Mild local irritation or erythema at the infusion site.
• Transient hyperglycemia, especially with rapid or large-volume administration.
• Nausea or a feeling of warmth during infusion.
• Headache or dizziness related to rapid changes in blood glucose.
• Transient increase in serum osmolality causing mild thirst.

Serious

• Severe hyperglycemia leading to osmotic diuresis or electrolyte disturbances.
• Hypersensitivity reactions such as urticaria, bronchospasm, or anaphylaxis.
• Volume overload or pulmonary edema in patients with compromised cardiac function.
• Acute renal impairment due to osmotic nephrosis in susceptible individuals.
• Metabolic acidosis secondary to excessive glucose metabolism in rare cases.

When using Glucose Fresenius, clinicians should observe several precautionary measures to minimize risks and ensure appropriate patient selection.

• Assess baseline blood glucose and monitor levels frequently during and after infusion.
• Adjust infusion rate in patients with diabetes, renal insufficiency, or heart failure to avoid hyperglycemia or fluid overload.
• Use aseptic technique to prevent contamination of the sterile solution.
• Verify compatibility with co‑administered drugs, as high glucose concentrations may affect stability.
• Avoid rapid large-volume boluses unless clinically indicated.
• Consider electrolyte status, particularly sodium and potassium, before administration.
• Document infusion parameters and patient response in the medical record.

Glucose Fresenius may interact with certain medications or clinical conditions, requiring careful consideration of compatibility and patient status.

Avoid

• Co‑administration with insulin or other hypoglycemic agents without adjusting doses, to prevent severe hypoglycemia.
• Simultaneous infusion of high‑concentration dextrose solutions with calcium‑containing medications, which can precipitate calcium phosphate.

Use with caution

• Concurrent use of diuretics or antihypertensives in patients at risk of fluid overload.
• Administration in patients receiving sodium‑containing fluids, to avoid hypernatremia.
• Use in individuals on beta‑blockers, as altered glucose metabolism may mask hypoglycemia symptoms.